Transcriptional regulation of MYC through G-quadruplex structures

Abstract The MYC gene codes for the expression of MYC (also known as c-Myc), a transcription factor that regulates the expression of diverse genes and is important for global transcriptional regulation. The deregulated expression of MYC has been observed in many cancers and is strongly associated with tumorigenesis. Although numerous strategies have been developed to target the MYC protein, it is considered “undruggable,” and there remains no drug for MYC-driven cancers. The expression of MYC is complex and tightly regulated at the transcriptional level. In this chapter, we describe efforts to understand and control one important transcriptional regulatory mechanism for MYC expression. This mechanism involves the formation of a non-B-DNA structure known as a G-Quadruplex (GQ) within the CT element (also known as the NHE III1 region) of the MYC promoter. We detail putative mechanisms by which GQ formation influences MYC transcription as well as recent examples of small molecules that target GQ structures to control MYC expression.

• Publication year

  2020

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Chemistry

• Identifiers
  DOI 10.1016/bs.armc.2020.05.002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Developing Novel G-Quadruplex Ligands: From Interaction with Nucleic Acids to Interfering with Nucleic Acid–Protein Interaction

  2019cited by this paper
• Indenoisoquinoline Topoisomerase Inhibitors Strongly Bind and Stabilize the MYC Promoter G-Quadruplex and Downregulate MYC.

  2019cited by this paper
• DDX5 helicase resolves G-quadruplex and is involved in MYC gene transcriptional activation

  2019cited by this paper
• Whole genome experimental maps of DNA G-quadruplexes in multiple species

  2019cited by this paper
• Faculty Opinions recommendation of Post-translational modification localizes MYC to the nuclear pore basket to regulate a subset of target genes involved in cellular responses to environmental signals.

  2019cited by this paper
• Abstract 5207: Functions of nucleolin in its interactions with the MYC promoter G-quadruplex

  2019cited by this paper
• Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription.

  2019cited by this paper
• Super-enhancers in cancer.

  2019cited by this paper
• Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer Therapy

  2019cited by this paper
• Mission Possible: Advances in MYC Therapeutic Targeting in Cancer

  2019cited by this paper
• Small Molecule Driven Stabilization of Promoter G-Quadruplexes and Transcriptional Regulation of c-MYC.

  2018cited by this paper
• The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer.

  2018cited by this paper
• Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex

  2018cited by this paper
• CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.

  2018cited by this paper
• Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches

  2018cited by this paper
• A Rare Missense Variant in TCF7L2 Associates with Colorectal Cancer Risk by Interacting with a GWAS-Identified Regulatory Variant in the MYC Enhancer.

  2018cited by this paper
• Targeting Super-Enhancers for Disease Treatment and Diagnosis

  2018cited by this paper
• Design of Modular G‐quadruplex Ligands

  2018cited by this paper
• Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism

  2018cited by this paper
• Crystal structure of the major quadruplex formed in the promoter region of the human c-MYC oncogene

  2018cited by this paper
• Kinetic evidence for interaction of TMPyP4 with two different G-quadruplex conformations of human telomeric DNA.

  2018cited by this paper
• Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex.

  2018cited by this paper
• Targeting oncogenic Myc as a strategy for cancer treatment

  2018cited by this paper
• Structural basis of G-quadruplex unfolding by the DEAH/RHA helicase DHX36

  2018cited by this paper
• Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex

  2018cited by this paper
• Simultaneous Binding of Hybrid Molecules Constructed with Dual DNA-Binding Components to a G-Quadruplex and Its Proximal Duplex.

  2018cited by this paper
• A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies

  2018cited by this paper
• Permanganate/S1 Nuclease Footprinting Reveals Non-B DNA Structures with Regulatory Potential across a Mammalian Genome.

  2017cited by this paper
• RNA G-Quadruplexes in Biology: Principles and Molecular Mechanisms.

  2017cited by this paper
• Specific G-quadruplex ligands modulate the alternative splicing of Bcl-X

  2017cited by this paper
• DNA G-quadruplexes in the human genome: detection, functions and therapeutic potential

  2017cited by this paper
• Discovery of RNA Binding Small Molecules Using Small Molecule Microarrays.

  2017cited by this paper
• Quadruplex nucleic acids as targets for anticancer therapeutics

  2017cited by this paper
• Recent advances in targeting mTOR signaling pathway using small molecule inhibitors

  2017cited by this paper
• CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours

  2017cited by this paper
• A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas.

  2017cited by this paper
• MYC—Master Regulator of the Cancer Epigenome and Transcriptome

  2017cited by this paper
• The effects of DNA supercoiling on G-quadruplex formation

  2017cited by this paper
• Targeting Cancer Cells with BET Bromodomain Inhibitors.

  2017cited by this paper
• Small molecule selectively suppresses MYC transcription in cancer cells

  2017cited by this paper
• Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).

  2017cited by this paper
• Strategies to Inhibit Myc and Their Clinical Applicability

  2017cited by this paper
• G-quadruplex unwinding helicases and their function in vivo.

  2017cited by this paper
• Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia

  2017cited by this paper
• MYC Deregulation in Primary Human Cancers

  2017cited by this paper
• Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA

  2017cited by this paper
• A Mechanosensor Mechanism Controls the G-Quadruplex/i-Motif Molecular Switch in the MYC Promoter NHE III1.

  2016cited by this paper
• Ibrutinib repurposing: from B-cell malignancies to solid tumors

  2016cited by this paper
• rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome

  2016cited by this paper
• BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects

  2016cited by this paper
• Strategically targeting MYC in cancer

  2016cited by this paper
• Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer

  2016cited by this paper
• Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study.

  2016cited by this paper
• Roles of eukaryotic topoisomerases in transcription, replication and genomic stability

  2016cited by this paper
• Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds

  2016cited by this paper
• Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors

  2016cited by this paper
• Structure-based Inhibitor Design for the Intrinsically Disordered Protein c-Myc

  2016cited by this paper
• β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1

  2016cited by this paper
• The role of enhancers in cancer

  2016cited by this paper
• IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation

  2016cited by this paper
• Systematic mapping of functional enhancer–promoter connections with CRISPR interference

  2016cited by this paper
• G-quadruplexes and helicases

  2016cited by this paper
• The molecular pathogenesis of chronic lymphocytic leukaemia

  2016cited by this paper
• MYC regulates the antitumor immune response through CD47 and PD-L1

  2016cited by this paper
• Targeting MYC in cancer therapy: RNA processing offers new opportunities

  2016cited by this paper
• Quadruplex Nucleic Acids as Novel Therapeutic Targets.

  2016cited by this paper
• Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers

  2015cited by this paper
• CDK7-dependent transcriptional addiction in triple-negative breast cancer.

  2015cited by this paper
• Ibrutinib in B lymphoid malignancies

  2015cited by this paper
• MYC: connecting selective transcriptional control to global RNA production

  2015cited by this paper
• High-throughput sequencing of DNA G-quadruplex structures in the human genome

  2015cited by this paper
• Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression

  2015cited by this paper
• MYC-mediated synthetic lethality for treatment of hematological malignancies.

  2015cited by this paper
• Safety and activity of DCR-MYC, a first-in-class Dicer-substrate small interfering RNA (DsiRNA) targeting MYC, in a phase I study in patients with advanced solid tumors.

  2015cited by this paper
• DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway

  2015cited by this paper
• Nucleolin stabilizes G-quadruplex structures folded by the LTR promoter and silences HIV-1 viral transcription

  2015cited by this paper
• Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer.

  2015cited by this paper
• MYC, Metabolism, and Cancer.

  2015cited by this paper
• G-quadruplexes and their regulatory roles in biology

  2015cited by this paper
• Promiscuous Rearrangements of the MYC Locus Hijack Enhancers and Super-Enhancers to Dysregulate MYC Expression in Multiple Myeloma

  2014cited by this paper
• An overview of MYC and its interactome.

  2014cited by this paper
• Synthetic lethal screens as a means to understand and treat MYC-driven cancers.

  2014cited by this paper
• Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics

  2014cited by this paper
• Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia

  2014cited by this paper
• FANCJ promotes DNA synthesis through G-quadruplex structures

  2014cited by this paper
• CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer.

  2014cited by this paper
• Mammalian MYC Proteins and Cancer

  2014cited by this paper
• Therapeutic strategies to inhibit MYC.

  2014cited by this paper
• Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5

  2014cited by this paper
• G‐Quadruplex Structures and Their Interaction Diversity with Ligands

  2014cited by this paper
• What are super-enhancers?

  2014cited by this paper
• Taking on challenging targets: making MYC druggable.

  2014cited by this paper
• The mechanisms behind the therapeutic activity of BET bromodomain inhibition.

  2014cited by this paper
• MYC and the control of apoptosis.

  2014cited by this paper
• Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients

  2014cited by this paper
• Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer

  2014cited by this paper
• G-quadruplexes are genomewide targets of transcriptional helicases XPB and XPD

  2014cited by this paper
• Transcriptional enhancers: from properties to genome-wide predictions

  2014cited by this paper
• Reprogramming the Mechanism of Action of Chlorambucil by Coupling to a G-Quadruplex Ligand

  2014cited by this paper
• Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.

  2014cited by this paper

• In Silico Design of Novel Artocarpus altilis-Derived Compounds Targeting the c-Myc/Max Heterodimer

  2025cites this paper
• Exploring RNA G‐Quadruplex Stability in the Gas Phase: Insights from Native Mass Spectrometry

  2025cites this paper
• Insights into the mechanism of binding of doxorubicin and a chlorin compound with 22-mer c-Myc G quadruplex.

  2023cites this paper
• Role of c-Myc in lung cancer: Progress, challenges, and prospects

  2023cites this paper
• Development and application of metallo-phthalocyanines as potent G-quadruplex DNA binders and photosensitizers

  2023cites this paper
• Major Achievements in the Design of Quadruplex-Interactive Small Molecules

  2022cites this paper
• A world beyond double-helical nucleic acids: the structural diversity of tetra-stranded G-quadruplexes

  2021cites this paper